Detailed Information for C00919

Basic information about inhibitors

IPAD-DB ID C00919
Name Bacoside-A
Category Natural compounds
2D Structure
3D Structure
Molecular Formula C 4 1 H 6 8 O 1 3
Molecular Weight 769.0 g/mol
IUPAC Name (5R, 8R, 9S, 10S, 13R, 14R, 17S)-3-[(2R, 3R, 4R, 5S, 6R)-3, 4-dihydroxy-6-(hydroxymethyl)-5-[(2S, 3R, 4S, 5S)-3, 4, 5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-10-(hydroxymethyl)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4, 4, 8, 14-tetramethyl-1, 2, 3, 5, 6, 7, 9, 11, 12, 13, 15, 17-dodecahydrocyclopenta[a]phenanthren-16-one
InChI InChI=1S/C41H68O13/c1-21(2)9-8-14-40(7, 50)29-22-10-11-27-38(5, 39(22, 6)17-23(29)44)15-12-26-37(3, 4)28(13-16-41(26, 27)20-43)53-36-33(49)31(47)34(25(18-42)52-36)54-35-32(48)30(46)24(45)19-51-35/h9, 22, 24-36, 42-43, 45-50H, 8, 10-20H2, 1-7H3/t22-, 24+, 25-, 26+, 27+, 28?, 29-, 30+, 31-, 32-, 33-, 34-, 35+, 36+, 38-, 39-, 40+, 41-/m1/s1
InChIKey LKCTWIIDXXXXAR-CYGHALRTSA-N
Canonical SMILES CC(=CCCC(C)(C1C2CCC3C(C2(CC1=O)C)(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)OC6C(C(C(CO6)O)O)O)O)O)CO)C)O)C
PubChem CID 92043183
DrugBank Accession Number -
CAS Registry Number 11028-00-5

Biological activity data

Ki -
EC50 -
IC50 -
Inhibition -
Toxicity -
ROS(reactive oxygen species) -
Metal Chelating -
BBB(blood-brain barrier) -
Target Protein Aβ1-42
Effects Exerted significant inhibitory effects upon cytotoxicity, fibrillation, and particularly membrane interactions of amyloid-beta (1-42)
Research Models In SH-SY5Y cells
Main Source Bacopa monniera plant
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 768.97
Hac(Computed by SwissADME) 54
Volume(Computed by ADMETlab 2.0) 775.353
Density(Computed by ADMETlab 2.0) 0.991
nRing(Computed by ADMETlab 2.0) 6
MaxRing(Computed by ADMETlab 2.0) 17
nHet(Computed by ADMETlab 2.0) 13
fChar(Computed by ADMETlab 2.0) 0
nRig(Computed by ADMETlab 2.0) 34
Flexibility(Computed by ADMETlab 2.0) 0.294
Stero Centers(Computed by ADMETlab 2.0) 18
LogS(Computed by ADMETlab 2.0) -3.284
LogD(Computed by ADMETlab 2.0) 2.525

ADMET properties

logP(Computed by ADMETlab 2.0) 2.749
TPSA(Computed by SwissADME) 215.83
Hbond Acceptor(Computed by SwissADME) 13
Hbond Donor(Computed by SwissADME) 8
Rotatable Bonds(Computed by SwissADME)

Pharmacokinetics

GI Absorption(Computed by SwissADME) Low
BBB(blood-brain barrier) Permeant(Computed by SwissADME) No
P-gp Substrate(Computed by SwissADME) Yes
CYP1A2 Inhibitor(Computed by SwissADME) No
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) No
CYP2D6 Inhibitor(Computed by SwissADME) No
CYP3A4 Inhibitor(Computed by SwissADME) No
log Kp(Skin Permeation)(Computed by SwissADME) -9.03

Druglikeness

Lipinski(Computed by SwissADME) 3
Ghose(Computed by SwissADME) 3
Veber(Computed by SwissADME) 1
Egan(Computed by SwissADME) 1
Muegge(Computed by SwissADME) 4
Bioavailability Score(Computed by SwissADME) 0.17